Medexus Pharmaceuticals Inc. (MEDXF)
USD 1.91
(-2.05%)
USD 1.91
(-2.05%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 112.55 Million | 108.09 Million | 108.09 Million | 76.7 Million | 79.66 Million | 25.36 Million |
| Cost of Revenue | 53.55 Million | 48.05 Million | 48.05 Million | 38.77 Million | 37.65 Million | 10.37 Million |
| Gross Profit | 59 Million | 60.03 Million | 60.03 Million | 37.92 Million | 42 Million | 14.98 Million |
| Operating Expenses | 48.72 Million | 51.54 Million | 51.54 Million | 50.3 Million | 41.27 Million | 15.66 Million |
| Selling, General and Administrative Expenses | 44.67 Million | 48.25 Million | 48.25 Million | 44.03 Million | 36.17 Million | 15.61 Million |
| Research and Development Expenses | 1.59 Million | 2.94 Million | 2.94 Million | 5.87 Million | 4.59 Million | - |
| Other Expenses | - | 353 Thousand | - | - | - | - |
| Cost and Expenses | 102.26 Million | 99.6 Million | 99.6 Million | 89.07 Million | 78.92 Million | 26.04 Million |
| Operating Income | 12.73 Million | 7.61 Million | 7.61 Million | -14.99 Million | -1.37 Million | -4.39 Million |
| Interest Expense | 13.36 Million | 13.6 Million | 13.6 Million | 12.22 Million | 9.81 Million | 2.9 Million |
| Income Tax Expense | 320 Thousand | -6.26 Million | -6.26 Million | -941 Thousand | -3.23 Million | 166.28 Thousand |
| Earnings before Tax | 106 Thousand | -5.04 Million | -5.04 Million | -3.82 Million | -31.5 Million | -4.71 Million |
| Net Income | -214 Thousand | 1.22 Million | 1.22 Million | -2.87 Million | -28.26 Million | -4.88 Million |
| Earnings Per Share Basic | -0.01 | 0.06 | 0.06 | -0.19 | -1.97 | -0.49 |
| Earnings Per Share Diluted | -0.01 | 0.06 | 0.06 | -0.19 | -1.97 | -0.49 |
| Weighted Average Shares Outstanding | 22.32 Million | 19.97 Million | 19.45 Million | 15.19 Million | 14.36 Million | 9.9 Million |
| Weighted Average Shares Outstanding (Diluted) | 22.32 Million | 20.52 Million | 19.45 Million | 15.19 Million | 14.36 Million | 9.9 Million |
| Gross Margin | 0.52 | 0.56 | 0.56 | 0.49 | 0.53 | 0.59 |
| EBIT Margin | 0.17 | 0.13 | 0.13 | -0.08 | 0.08 | 0.06 |
| Profit Margin | -0.00 | 0.01 | 0.01 | -0.04 | -0.35 | -0.19 |
| EBITDA | 19.27 Million | 14.64 Million | 14.54 Million | -6.23 Million | 5.24 Million | 119.08 Thousand |
| Earnings Before Tax Margin | 0.11 | 0.07 | 0.07 | -0.20 | -0.02 | -0.17 |
| Breakdown | 2024 Q4 | 2024 FY | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
|---|---|---|---|---|---|---|
| Revenue | 25.84 Million | 112.55 Million | 25.21 Million | 30.32 Million | 31.55 Million | 108.09 Million |
| Cost of Revenue | 12.66 Million | 53.55 Million | 12.51 Million | 14.04 Million | 14.31 Million | 48.05 Million |
| Gross Profit | 13.18 Million | 59 Million | 12.69 Million | 16.27 Million | 17.23 Million | 60.03 Million |
| Operating Expenses | 10.37 Million | 46.27 Million | 11.12 Million | 12.72 Million | 12.39 Million | 51.54 Million |
| Selling, General and Administrative Expenses | 10.32 Million | - | 9.11 Million | 10.28 Million | 10.39 Million | - |
| Research and Development Expenses | 52.76 Thousand | - | 1.94 Million | 2.36 Million | 1.94 Million | - |
| Other Expenses | - | - | - | - | - | 353 Thousand |
| Cost and Expenses | 23.03 Million | 99.82 Million | 23.64 Million | 26.77 Million | 26.71 Million | 99.6 Million |
| Operating Income | 2.81 Million | 12.73 Million | 1.56 Million | 3.55 Million | 4.84 Million | 7.61 Million |
| Interest Expense | 2.22 Million | 13.36 Million | 2.65 Million | 4.22 Million | 4.25 Million | 13.6 Million |
| Income Tax Expense | 226.98 Thousand | 318.59 Thousand | -261 Thousand | 120 Thousand | 233 Thousand | -6.26 Million |
| Earnings before Tax | 985.57 Thousand | 105.53 Thousand | -795 Thousand | -973 Thousand | 884 Thousand | -5.04 Million |
| Net Income | 762 Thousand | -213.06 Thousand | -534 Thousand | -1.09 Million | 651 Thousand | 1.22 Million |
| Earnings Per Share Basic | 0.03 | - | -0.02 | -0.05 | 0.03 | - |
| Earnings Per Share Diluted | 0.03 | - | -0.02 | -0.05 | 0.03 | - |
| Weighted Average Shares Outstanding | 24.45 Million | 22.32 Million | 24.18 Million | 20.43 Million | 20.23 Million | 19.97 Million |
| Weighted Average Shares Outstanding (Diluted) | 24.45 Million | 22.32 Million | 24.18 Million | 20.43 Million | 20.23 Million | 20.52 Million |
| Gross Margin | 0.51 | 0.52 | 0.50 | 0.54 | 0.55 | 0.56 |
| EBIT Margin | 0.16 | - | 0.12 | 0.17 | 0.20 | - |
| Profit Margin | 0.03 | -0.00 | -0.02 | -0.04 | 0.02 | 0.01 |
| EBITDA | 4.25 Million | - | 3.01 Million | 5.01 Million | 6.28 Million | - |
| Earnings Before Tax Margin | 0.11 | 0.11 | 0.06 | 0.12 | 0.15 | 0.07 |
MKC-V
0244
ICI
007070
002080
4406